Viewing nowCrestor 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

MFDS item code 200210097 · Approved 2002.01.15 · Insurance code 650700520
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
This medication is primarily used for the treatment of hypercholesterolemia and hyperlipidemia. It is particularly used as an adjunct when nutrition and exercise are insufficient to control primary hypercholesterolemia, including familial hypercholesterolemia and mixed dyslipidemia. It is also utilized as an adjunct to diet therapy in pediatric patients with specific criteria for heterozygous familial hypercholesterolemia. Additionally, it is beneficial for patients with dysbetalipoproteinemia. This drug lowers total cholesterol and LDL cholesterol, delaying the progression of atherosclerosis and effectively reducing the risk of stroke, myocardial infarction, and arterial revascularization procedures in middle-aged and older patients with elevated high-sensitivity C-reactive protein and cardiovascular risk factors. Therefore, this medication is used for hyperlipidemia and to decrease cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Age 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, it should not be administered to individuals with an allergy to this drug, patients with liver disease, myopathy, severe kidney impairment, or women who are pregnant or breastfeeding. Before taking this medication, it is essential to periodically examine liver function and muscle condition, particularly for patients with a history of liver disease or significant alcohol intake. If symptoms such as muscle pain or weakness occur, inform a physician immediately. Furthermore, this drug may interact with other medications, so it is crucial to inform healthcare providers of any medications being taken. Certain medications may elevate the blood concentration of this drug, increasing the risk of muscle damage. Women who may become pregnant should use appropriate contraception while taking this medication and must discontinue usage immediately if they become pregnant. It is also advised that breastfeeding women avoid taking this medication. In case of an overdose, there is no specific antidote, and treatment should be symptomatic, with monitoring of liver function and muscle enzyme levels. This drug may cause side effects such as dizziness, so caution is advised when driving or operating machinery. Lastly, this drug may show higher concentrations in Asians, and dosage adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug-induced psoriasiform rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paraesthesia, chest discomfort, decreased appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Storing it this way helps ensure the drug's effectiveness is preserved.
Pink round film-coated tablet
30 tablets/bottle, 30 tablets (15 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kyeongbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.